REFERENCES
- Boulant JA. Thermoregulation. In: Mackowiak PA, ed. Fever: Basic mechanisms and management. 2nd ed. New York: Lippincott-Raven, 1997: 35-58.
- Cooper KE. Some responses of the cardiovascular system to heat and fever. Can J Cardiol 1994; 10: 444–8.
- Kushner I, Rzewnicki DL. The acute phase response. In: Mackowiak PA, ed. Fever: Basic mechanisms and management. 2nd ed. New York: Lippincott-Raven, 1997: 167-76.
- Ballard BE. Pharmacokinetics and temperature. J Pharm Sci 1974; 63: 1345–58.
- Mackowiack PA. Influence of fever on pharmacokinetics. Rev Infect Dis 1989; 11: 804–7.
- Sarwari AR, Mackowiak PA. The pharmacologic consequences of fever. Infect Dis Clin North Am 1996; 10: 21–32.
- Pennington JE, Dale DC, MacLowry JD. Gentamicin sulfate pharmacokinetics: lower levels of gentamicin in blood during fever. J Infect Dis 1975; 132: 270–5.
- Siber GR, Echeverria P, Smith Al, Paisley JW, Smith DH. Pharmacokinetics of gentamicin in children in adults. J Infect Dis 1975; 132: 637–51.
- Demotes-Mainard F, Albin H, Ragnaud JM, Gin H, Vincon G, Aubertin J. Influence de l'hyperthermie sur la pharmacocinEtique du cefotaxime. Pathol Biol 1988; 36: 155–8.
- Acharya G, Crevoisier C, Butler T, Ho M, Tiwari M, Stoeckel K, Bradley CA. Pharmacokinetics of ceftriaxone in patients with typhoid fever. Antimicrob Agents Chemother 1994; 38: 2415–8.
- Ljungberg B, Nilsson-Ehle I. Advancing age and acute infection influence the kinetics of ceftazidime. Scand J Infect Dis 1989; 21: 327–32.
- Lortholary O, Tod M, Rizzo N, et al. Population pharmacokinetic study of teicoplanin in severely neutropenic patients. Antimicrob Agents Chemother 1996; 40: 1242–7.
- Johansen K, Krogh M, Andersen AT, Christophersen AS, Lehne G, Rasmusen KE. Automated analysis of free and total concentrations of three antiepileptic drugs in plasma with online dialysis and high-performance liquid chromatography. J Chromatogr 1995; 669: 281–8.
- Nightingale CH, Bassaris H, Tilton R, Quintiliani R. Changes in pharmacokinetics of cefazolin due to stress. J Pharmaceut Sci 1974; 64: 712–4.
- Rowland M, Tozer TN. Clinical pharmacokinetics. 2nd ed. Philadelphia: Lea & Febiger, 1989: 197–212.
- Ganzinger U, Halsberger A. Pharmacokinetics of cephalosporins in normal and septicemic rabbits. Antimicrob Agents Chemother 1985; 28: 473–7.
- Halkin H, Lidji M, Rubinstein E. The influence of endotoxin-induced pyrexia on the pharmacokinetics of gentamicin in the rabbit. J Pharmacol Exp Ther 1981; 216: 415–8.
- LadefOged O. Pharmacokinetics of trimethoprim (TMP) in normal and febrile rabbits. Acta Pharmacol Toxicol 1977; 41: 507–14.
- Nadai M, Hasegawa T, Kato K, Wang L, Nabeshima T, Kato N. Alteration in pharmacokinetics and protein binding behavior of cefazolin in endotoxemic rats. Antimicrob Agents Chemother 1993; 37: 1781–5.
- Wilson RC, Goetsch DD, Huber TL. Influence of endo-toxin-induced fever on the pharmacokinetics of gentamicin in ewes. Am J Vet Res 1984; 45: 2495–7.
- Zeng ZL, Fung KF. Effects of experimentally induced Streptococcus suis infection on the pharmacokinetics of penicillin G in pigs. J Vet Pharmacol Ther 1990; 13: 43–8.
- Riffat S, Nawaz M, Ziaur-Rehman. Pharmacokinetics of sulphadimidine in normal and febrile dogs. J Vet Pharmacol Therap 1982; 5: 131–5.
- Nadai M, Hasegawa T, Kato K, Wang I, Nabeshima T, Kato N. Influence of a bacterial lipopolysaccharide on the pharmacokinetics of tobramycin in rats. J Pharm Pharmacol 1993; 45: 971–4.
- Leszczynska A. The effect of pyrogen induced fever on pharmacokinetics of rifamycin SV. Pol J Pharmacol Pharm 1979; 31: 19–24.
- Kucers A, N. McK. Bennett NMcK, Kemp RJ. The use of antibiotics. London: William Heinemann Medical Books, 1987: 381–97.